Eco Animal Health Group Plc

• 02/05/12

  Holding(s) in Company

• 14/03/12

  Director/PDMR Shareholding

• 26/01/12

  Holding(s) in Company

• 18/01/12

  Holding(s) in Company

• 16/01/12

  Issue of Equity

• 

  29/11/11

  Canada and US could provide over third of ECO Animal Health’s future market, says Cenkos

  Canada and the United States can provide over a third of the potential world market for ECO Animal Health’s products, according to analysts at City broker Cenkos.

   

• 

  22/07/11

  ECO Animal Health Group’s shares higher after it delivers upbeat results

  Very strong progress in China, India and Japan helped ECO Animal Health to increase overall sales by more than a quarter last year. Meanwhile, the firm said its current year has started well too. House broker Cenkos believes the shares could be worth 600 pence each

• 

  03/02/11

  ECO Animal Health: growing fast while awaiting US launch

  The livestock therapeutic specialist is continuing organic growth in China, Latin America and India.  In the shorter term, investors will want to look out for news of US regulatory approval for its flagship product Aivlosin this year as well as full-year results that are expected to show a substantial increase in both turnover and profits. Longer term, a trade sale may be on the cards, chairman Peter Lawrence tells Proactive Investors.

• 

  11/03/10

  Eco Animal Health Group: moves into US and China could be transformational

  Aivlosin® now accounts for more than half of global sales for ECO. Sales in China during FY 2009 were more than 60% ahead of the previous year, and expectations for FY 2010 indicate similar progress.

• 

  23/09/09

  Eco Animal Health: helping the meat industry to stay in good shape

  The group’s flagship product is Aivlosin, which helps control diseases in pigs and chickens, but has potential for use in a wider range of animals

• 12/12/11

  ECO Animal Health reports strong interim results; sees upbeat second half - UPDATE

• 12/12/11

  ECO Animal Health reports strong interim results; sees upbeat second half

• 28/11/11

  ECO Animal Health shares rise after Canadian regulatory approval

• 22/07/11

  ECO Animal Health Group reports upbeat results, says demand strong in China

• 01/07/11

  Positive trends at ECO Animal Health

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for global animal health markets. Our products for these growth markets promote well-being in animals. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders. accordance with the applicable Scheme.

The Board of Eco Animal Health Group plc is committed to providing shareholders and other interested parties with a high level of disclosure to keep them properly informed and up to date with events at the Company.

Proprietary patented drugs

Aivlosin® - macrolide antibiotic for treatment of respiratory & enteric diseases in pigs and poultry.

Information on Aivlosin

Generic drugs

Ecomectin®, Ecoheart, Ecotraz & Ecomintic (endectocides & other antiparasitics) for treatment & prevention of parasites in cattle, sheep, pigs, horses and dogs.

Chlortet & Oxytet for treatment of bacterial infections in pigs, poultry & cattle.

For further information, visit our websites;

    * www.ecoanimalhealth.com
    * www.aivlosin.com

Peter A Lawrence BSc MSc - Chairman

Peter is a founder of the business and has been an executive director ever since its formation in 1972. He is the non-executive chairman of Baronsmead AIM VCT plc and a non-executive director of Baronsmead VCT plc, Noble AIM VCT plc, Kiotech International plc and Higher Nature Ltd.

Marc Loomes,BVSc, MRCVS - Director

Marc is a veterinary surgeon and a Member of the Royal College of Veterinary Surgeons in London. He also holds a post graduate degree in animal reproduction obtained in South Africa. Marc joined ECO Animal Health in October 2004 having gained extensive international experience of the animal health and crop protection industries in senior management roles for blue chip multi-national companies in South Africa, Germany, Switzerland and the UK.

Kevin Stockdale, BSc ACA - Finance Director

Kevin qualified as a Chartered Accountant in 1990 and was Finance Director of Interpet Ltd responsible for the audited accounts of Lawrence PLC while Interpet was a subsidiary company in the group. Interpet was sold in 2004 and Kevin remained with it as Finance Director. He rejoined the group in September 2007 as Finance Director.

Julia Trouse - Executive Director

Julia joined the group in 1993 as Financial Controller of Petworld Superstores Ltd and became Group Financial Controller of Lawrence plc in 1999 and Company Secretary in 2004. She joined the Board in September 2007.

Brett Clemo,BA (Hons) - Executive Director

Brett joined the Eco Animal Health Limited in 2006 as Director of Global Operations from Syngenta Chemicals BV where he became Operations Director and had previously spent 19 years with Syngenta, AstraZeneca and ICI in senior management roles.

David Danson - Non-Executive Director

David is a veterinary surgeon who has spent the majority of his career in the international veterinary pharmaceutical sector. Before moving into general management he was Director-Global Marketing for Chicago-based Mallinckrodt Animal Health Inc. He is currently Chief Operating Officer of Safeguard Biosystems (Holdings) Ltd, a biotech company in the human, animal and plant diagnostics field. He is also Chairman of Forsite Diagnostics Ltd, and RVC Developments Ltd and a Non-Executive Director of Moredun Scientific Ltd. He was previously CEO of UA Group plc which he led to a £54M sale in 2005. In addition, David is a Member of the Council of the Royal Veterinary College in the University of London and a member of the Advisory Board of the Detection and Identification of Infectious Agents programme of the UK government’s Technology Strategy Board.

Julia Henderson - Non- Executive Director

Julia has been involved with entrepreneurial growth companies in a wide range of sectors for over twenty years. She is an independent non-executive director and corporate consultant with quoted and private mid market companies. Julia is also non-executive chairman of GTL Resources plc and a non-executive director of Alkane Energy plc. She was a founder member and a director of Beeson Gregory Limited (now Evolution Securities), the mid market investment bank, and has a wealth of City experience.

Eco Animal Health Group plc are currently traded on Aim and Plus markets.

Major Shareholders over 3% as at 21st October 2011

Updated from company website 13/12/2011

Connect with Facebook to view or add comments for this company